Middle East, North Africa, Afghanistan & Pakistan vs Serbia: Treatment for hypertension, female

Middle East, North Africa, Afghanistan & Pakistan
48.4%
in 2019
Serbia
67.7%
in 2019
Middle East, North Africa, Afghanistan & Pakistan rank
16th
Serbia rank
18th

Treatment for hypertension, female over time

  • Middle East, North Africa, Afghanistan & Pakistan
  • Serbia
0204060199020042019

How they compare

Serbia currently reports 67.7% against 48.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 19.3%.

That makes Serbia's figure about 1.4 times Middle East, North Africa, Afghanistan & Pakistan's.

Across all 30 years both countries report, Serbia has been ahead every year.

Middle East, North Africa, Afghanistan & Pakistan ranks 16th and Serbia ranks 18th of 43 groups.

Serbia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Middle East, North Africa, Afghanistan & Pakistan Serbia Difference Ahead
1990s 30.0% 41.0% 11.0% Serbia
2000s 40.2% 56.2% 16.0% Serbia
2010s 47.7% 65.7% 18.0% Serbia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher treatment for hypertension, female, Middle East, North Africa, Afghanistan & Pakistan or Serbia?
Serbia, at 67.7% against 48.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2019.
What is the difference in treatment for hypertension, female between Middle East, North Africa, Afghanistan & Pakistan and Serbia?
19.3%, with Serbia ahead.
How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Serbia?
30 years are reported by both, from 1990 to 2019.
How do Middle East, North Africa, Afghanistan & Pakistan and Serbia rank globally for treatment for hypertension, female?
Middle East, North Africa, Afghanistan & Pakistan ranks 16th and Serbia ranks 18th of 43 groups.
Where does this data come from?
World Health Organization's Global Health Observatory Data Repository, published as Treatment for hypertension, female (% of female adults ages 30-79 with hypertension). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Middle East, North Africa, Afghanistan & Pakistan vs Serbia: Treatment for hypertension, female. Statizoid, drawing on World Health Organization's Global Health Observatory Data Repository. Retrieved 18 September 2026, from https://health.statizoid.com/compare/treatment-for-hypertension-female-percent-of-female-adults-ages-30-79-with-hypertension/middle-east-north-africa-afghanistan-and-pakistan/serbia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/treatment-for-hypertension-female-percent-of-female-adults-ages-30-79-with-hypertension/middle-east-north-africa-afghanistan-and-pakistan/serbia/">Middle East, North Africa, Afghanistan & Pakistan vs Serbia: Treatment for hypertension, female</a> — Statizoid

About this data

Indicator
Treatment for hypertension, female (% of female adults ages 30-79 with hypertension)
Unit
% of female adults ages 30-79 with hypertension
Source
World Health Organization's Global Health Observatory Data Repository
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
235 places, 7,050 data points, 1990–2019
Last refreshed

Treatment for hypertension is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.